Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. N Engl J Med. 2024 Aug 22; 391(8):710-721.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Basic Helix-Loop-Helix Transcription Factors
Carcinoma, Renal Cell
Everolimus
Female
Humans
Indenes
Kaplan-Meier Estimate
Kidney Neoplasms
Male
Middle Aged
Treatment Outcome
Young Adult
authors with profiles
Walter M. Stadler